SPRAVATO® Treatment Centers: What to Expect at Your First Appointment

First Spravato appointment milwaukee wi

You’ve researched SPRAVATO® extensively, discussed it with your psychiatrist, and decided this FDA-approved esketamine nasal spray might be the treatment-resistant depression solution you’ve been seeking. The FDA approved SPRAVATO® in 2019 specifically for adults with treatment-resistant depression who haven’t responded to at least two different antidepressant medications (FDA, 2019). Now comes the practical question: what actually happens when you walk through the door of a certified SPRAVATO® treatment center for your first appointment?

What Makes SPRAVATO® Treatment Centers Different

SPRAVATO® isn’t available at every clinic or doctor’s office. The FDA requires a Risk Evaluation and Mitigation Strategy (REMS) program, meaning only certified healthcare settings can provide this treatment (FDA, 2019). This certification process ensures your safety through specific monitoring protocols and trained staff.

At Edelica Health, we’ve held SPRAVATO® certification since the treatment became available, and our team has the specialized training required to administer esketamine safely. Our board-certified anesthesiologist, Dr. Kevin Kane, brings over eight years of experience with ketamine-based treatments and has overseen more than 10,000 ketamine infusions since founding our clinic in 2017. This depth of experience with ketamine medications means we understand not just the protocols, but the nuances of how patients respond to treatment.

The certification requirements exist because SPRAVATO® can cause sedation, dissociation, and temporary increases in blood pressure. These effects require professional monitoring in a controlled medical environment rather than home administration.

Your First Appointment Timeline: What to Expect Hour by Hour

SPRAVATO® treatment sessions take longer than a typical doctor’s appointment. You should plan for approximately two and a half to three hours at the treatment center for your first visit.

Before Administration (15–30 minutes)

We’ll start by checking your vital signs, including blood pressure, heart rate, and oxygen levels. These baseline measurements help us monitor how you respond to the medication. You’ll also complete a brief assessment of your current depression symptoms so we can track improvement over time.

We require that you haven’t eaten for at least two hours before treatment and have avoided liquids for 30 minutes. This reduces nausea risk, which some patients experience. If you regularly take blood pressure medication, we’ll discuss timing since SPRAVATO® temporarily raises blood pressure.

You’ll need to use the restroom before treatment begins since you’ll be monitored continuously for two hours afterward and won’t be able to get up and move around freely during that period.

Self-Administration (5–10 minutes)

Here’s what surprises many patients: you’ll administer the SPRAVATO® nasal spray yourself under our direct supervision. We provide thorough instructions and demonstrate the technique. The device is designed to be user-friendly, but we’re right there to answer questions and ensure you’re using it correctly.

You’ll blow your nose gently before administration to ensure the best possible medication absorption. Then you’ll use the first nasal spray device to self-administer one puff in each nostril. After resting for five minutes, you’ll administer a second set of sprays, and for most people, a third set five minutes after that. Most patients use two or three nasal spray devices during a single treatment session, with a five-minute rest period between each device. You’ll recline in a comfortable treatment chair in a private room during administration. The nasal spray has a slightly bitter taste that some patients notice in the back of their throat, but this typically passes quickly. We provide Jolly Rancher candies to offset the bitter taste.

Monitoring Period (2 hours minimum)

After you’ve used all prescribed nasal spray devices, the mandatory monitoring period begins. This is not optional—the REMS program requires us to observe you for at least two hours before you can leave (FDA, 2019).

During this time, you’ll remain in your private treatment room, reclining comfortably. We check your vital signs regularly and assess for side effects. Many patients experience some degree of dissociation, which can feel like detachment from your surroundings or altered perception. This is expected and temporary. Some describe it as feeling dreamy or floating, while others notice visual changes or feel distant from their body.

We keep the environment calm and quiet. You’re welcome to bring headphones and listen to music, though many patients prefer simply resting with their eyes closed. We dim the lights to reduce stimulation and help you feel comfortable during the experience.

Sedation is common, and some patients doze off during the monitoring period. We’ll gently check on you periodically to ensure you’re stable and comfortable. These effects peak within the first 30 to 60 minutes after administration and gradually diminish.

Clearance to Leave (15–30 minutes)

Before you can go home, we need to confirm that acute dissociation and sedation have resolved adequately. We’ll reassess your symptoms and check your vital signs one final time. You should feel mostly back to baseline, though some patients report lingering mild lightheadedness or tiredness for a few hours.

You absolutely cannot drive yourself home after SPRAVATO® treatment. You must arrange for someone to drive you, or you can use a ride service. This isn’t a suggestion—it’s a safety requirement. We won’t allow you to leave unless we’ve confirmed you have safe transportation arranged.

Preparing for Your First SPRAVATO® Appointment

What to Bring

Bring a list of all current medications, including over-the-counter supplements. Certain medications can interact with SPRAVATO®, and we need a complete picture of what you’re taking. We also need to keep track of any changes to your medications and dosages.

Also bring your insurance information. It is important to let us know before your treatment if your insurance changes, to prevent a denial if you’re seeking coverage, though many patients find they need to appeal initial denials for SPRAVATO® coverage.

Wear comfortable clothing since you’ll be reclining for several hours. Avoid tight waistbands or restrictive clothing around your chest or abdomen. Some patients bring a light blanket or wear layers since temperature comfort varies during treatment.

Consider bringing headphones and a calming playlist if music helps you relax. Leave valuables at home since you’ll be in an altered state during part of the treatment and won’t want to worry about personal items.

Arranging Transportation

Schedule your ride home in advance. Don’t assume you’ll feel well enough to take public transportation or that a rideshare will be readily available when you’re ready to leave. Having a trusted friend or family member pick you up is ideal since they can stay with you for the first few hours after you get home.

Food and Medication Timing

Eat a light meal about three to four hours before your appointment. This gives you enough time to digest so you’re not treating on an empty stomach, but you’re also meeting the two-hour fasting requirement. Avoid heavy, greasy foods before treatment as these can worsen nausea.

Ask us during your initial consultation about timing for your regular medications. Some need to be taken as usual, while others should be held until after treatment.

What Happens After Your First Treatment

Most patients don’t notice dramatic improvement after a single SPRAVATO® treatment. Clinical trials showed that meaningful response typically develops over several weeks of consistent treatment (Maust et al., 2022). The standard protocol involves twice-weekly treatments for the first four weeks, then weekly treatments for the following four weeks, followed by treatment every other week or weekly as needed for maintenance.

You may feel tired or slightly “off” for the remainder of the day after your first treatment. This is normal. We recommend taking it easy for the rest of the day—this isn’t the day to tackle demanding mental or physical tasks. Most patients return to normal activities the following day.

Some patients experience mild nasal discomfort or nosebleeds, especially if you have sensitive nasal passages. This typically improves as your body adjusts to the treatment. Others notice temporary changes in sense of taste or smell.

Depression symptoms may fluctuate in the days following your first treatment. Some patients report feeling slightly worse before improvement begins, while others notice subtle positive shifts relatively quickly. Track your symptoms between treatments so you and your treatment team can assess response patterns.

Common Questions About the First SPRAVATO® Appointment

How is SPRAVATO® different from IV ketamine?

Both SPRAVATO® and IV ketamine work through similar mechanisms in the brain, but SPRAVATO® is the FDA-approved nasal spray form of esketamine administered in certified centers with mandatory monitoring, while IV ketamine is the racemic mixture used off-label through intravenous infusion. IV ketamine tends to be a little more intense of a treatment (depending on the dose), and SPRAVATO® tends to be a bit gentler, with a lighter level of dissociation. SPRAVATO® may have insurance coverage options since it’s FDA-approved for treatment-resistant depression, while IV ketamine typically requires private pay.

Will the first treatment help my depression?

Some patients notice subtle mood improvements after their first SPRAVATO® treatment, but most experience gradual improvement over several weeks of consistent treatment. Research shows that response rates improve with each subsequent treatment during the induction phase (Maust et al., 2022). Think of it like physical therapy—one session rarely fixes the problem, but consistent treatment over time produces meaningful results. We track your progress carefully throughout the treatment course.

Can I take my regular antidepressant along with SPRAVATO®?

Yes, SPRAVATO® is designed to be used alongside an oral antidepressant medication. The FDA approval specifically requires concurrent use with an oral antidepressant (FDA, 2019). You’ll continue your current antidepressant regimen while adding SPRAVATO® treatments. Don’t stop or change your antidepressant medications without discussing it with your prescribing physician.

What if I have a bad reaction during my first treatment?

Our clinical team monitors you continuously during the two-hour observation period precisely to address any concerning reactions immediately, with protocols for managing side effects like blood pressure increases, severe dissociation, or excessive sedation. Dr. Kane’s background as a board-certified anesthesiologist means we have the expertise to handle medical complications should they arise, though serious adverse events are uncommon in properly certified settings.

How much does the first SPRAVATO® appointment cost?

SPRAVATO® treatment costs vary based on your insurance coverage and our clinic’s pricing structure. Some insurance plans cover SPRAVATO® after prior authorization demonstrating treatment-resistant depression, while others deny coverage requiring private pay or appeals. We provide transparent pricing information during your initial consultation and can discuss whether pursuing insurance coverage makes sense for your situation. Many patients find that the cost per treatment decreases as they move from twice-weekly induction treatments to less frequent maintenance treatments.

Making the Decision: Is SPRAVATO® Right for You

SPRAVATO® represents a significant commitment of time and resources. Before scheduling your first appointment, consider whether you can reliably attend twice-weekly treatments for at least a month. Transportation arrangements, work schedule flexibility, and the ability to take it easy on treatment days all factor into success.

Your treatment team should have thoroughly reviewed your history of antidepressant trials to confirm you meet treatment-resistant depression criteria. SPRAVATO® is specifically approved for patients who haven’t adequately responded to at least two different antidepressant medications, so documenting this treatment history is essential.

Consider your support system. Having someone who can drive you to and from treatments and potentially stay with you for a few hours afterward makes the process easier and safer. Some patients involve family members in their treatment planning so everyone understands the time commitment and logistics.

Understanding what happens at your first SPRAVATO® appointment removes much of the uncertainty that can create anxiety about trying a new treatment. The structured environment, mandatory monitoring, and certification requirements exist to protect your safety while giving you access to an effective treatment for depression that hasn’t responded to traditional approaches.

If you’re ready to explore SPRAVATO® treatment for treatment-resistant depression, Edelica Health offers certified SPRAVATO® administration in a safe, comfortable environment. Our team has extensive experience with ketamine-based treatments and understands both the clinical protocols and the patient experience. Schedule your complimentary SPRAVATO® consultation to determine if you’re a candidate for this FDA-approved treatment. Call 414-441-5707.

References

FDA. (2019). FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic. https://www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified

Maust, D.T., et al. (2022). Esketamine for Treatment-Resistant Depression. JAMA Network. https://jamanetwork.com/journals/jama/fullarticle/2796097

Medical Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Treatment response varies by individual, and SPRAVATO® outcomes cannot be guaranteed. Always consult qualified healthcare providers about your specific condition and treatment options. SPRAVATO® should only be administered under professional medical supervision in certified treatment centers.

Request Your Free Consultation